dipyridamole has been researched along with Delayed Hypersensitivity in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salava, A | 1 |
| Alanko, K | 1 |
| Hyry, H | 1 |
| Mikhaĭlova, S | 1 |
| Gancheva, G | 1 |
| Koĭchev, Ch | 1 |
2 other studies available for dipyridamole and Delayed Hypersensitivity
| Article | Year |
|---|---|
Dipyridamole-induced eczematous drug eruption with positive patch test reaction.
Topics: Cerebral Infarction; Dipyridamole; Drug Eruptions; Humans; Hypersensitivity, Delayed; Male; Middle A | 2012 |
[Effect on the primary humoral and cell-mediated immune responses of dipyridamole].
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Dipyridamole; Dose-Response Relationship, Dru | 1984 |